Dublin, June 24, 2019 (GLOBE NEWSWIRE) — The “Global Hyaluronic Acid Market Projected to Reach $15.25 Billion by 2026″ report has been added to ResearchAndMarkets.com’s offering. The global hyaluronic acid market size is expected to reach USD 15.25 billion by 2026 registering a CAGR of 7.8%.Factors, such as increasing concern about toxic chemicals, need for quick and evident results, and shorter recovery time are high impact rendering drivers of this market. The market is witnessing rapid growth due to increasing adoption of aesthetic procedures across the globe.Wide usage of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving the compatibility coupled with growing awareness about anti-aging products is driving the market. In addition, increasing cases of obesity indicate a rising number of people suffering from orthopedic disorders, which do not have any permanent cure and the treatments include pain-killers. However, hyaluronic acid-based viscosupplements are expected to be a possible cure for joint pain. Orthovisc, approved in 2013, and Monovisc, approved in 2016, by Anika Therapeutics, Inc. are among the popular viscosupplements.Increasing popularity of cosmetic surgeries across the globe is also expected to boost the market growth. In 2013, hyaluronan-based facial fillers received FDA approval, which is used in corrective measures, anti-aging procedure, and filling fine lines. North America led the market in 2018. Presence of key companies, such as Genzyme Corporation and Anika Therapeutics, in this region contributes to market growth. Increasing number of anti-aging procedures performed and resultant demand for dermal fillers are expected to drive the regional market further.
Post time: Jun-29-2019